Lorlatinib post-reimbursement price

Lorlatinib (Lorlatinib) is an innovative drug used to treat non-small cell lung cancer (NSCLC). Its primary indication is the treatment of patients with advanced or metastatic NSCLC that is positive for ALK (tyrosine kinase) mutations.

Lorlatinib has been launched in China and is included in medical insurance. Patients can purchase it domestically, but the price is relatively high, about 10,000 to 20,000 yuan. For details, please consult the local hospital pharmacy. There are original drugs and cheaper generic drugs abroad. The cheaper ones are the original drugs from Turkey, which cost more than 1,000 yuan, and the original drugs from Hong Kong, China, which cost about 30,000 yuan. Generic drugs are mainly generic drugs from Laos and Bangladesh. The price is about several thousand yuan, and the ingredients of the original drugs and generic drugs are basically the same.

The mechanism of action of this drug is to interfere with the abnormal signaling of cancer cells by inhibiting the activity of ALK and ROS1 proteins, thereby preventing the growth and spread of tumors. Lorlatinib is unique in its ability to overcome some of the resistance issues seen with other treatments and is therefore considered an important treatment option.

In terms of usage, patients usually take 100 mg of lorlatinib orally once a day, preferably on an empty stomach or at least two hours after a meal to ensure optimal absorption.

However, the use of lorlatinib may be associated with some side effects, including fatigue, cough, shortness of breath, nausea, vomiting, headache, high blood pressure, etc. Therefore, the patient's physical condition needs to be closely monitored during treatment and managed according to the doctor's recommendations. In particular, lorlatinib may cause severe pneumonia and visual disturbances, so patients need regular lung and vision examinations. Additionally, interactions with other medications need to be carefully considered, so patients should inform their doctor about all medications they are taking.